Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 17;22(6):526-532.
doi: 10.1002/cphc.202000831. Epub 2021 Feb 16.

The Cytotoxic Effect of α-Synuclein Aggregates

Affiliations

The Cytotoxic Effect of α-Synuclein Aggregates

Francisco Melo et al. Chemphyschem. .

Abstract

Parkinson's disease is a neurodegenerative disorder involving a functional protein, α-synuclein, whose primary function is related to vesicle trafficking. However, α-synuclein is prone to form aggregates, and these inclusions, known as Lewy bodies, are the hallmark of Parkinson's disease. α-synuclein can alter its conformation and acquire aggregating capacity, forming aggregates containing β-sheets. This protein's pathogenic importance is based on its ability to form oligomers that impair synaptic transmission and neuronal function by increasing membrane permeability and altering homeostasis, generating a deleterious effect over cells. First, we establish that oligomers interfere with the mechanical properties of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) membrane, as demonstrated by nanoindentation curves. In contrast, nanoindentation revealed that the α-synuclein monomer's presence leads to a much more resistant lipid bilayer. Moreover, the oligomers' interaction with cell membranes can promote lactate dehydrogenase (LDH) release, suggesting the activation of cytotoxic events.

Keywords: Parkinson's disease; aggregates; membrane; nanoindentation; toxicity.

PubMed Disclaimer

References

    1. V. L. Feigin, A. A. Abajobir, K. H. Abate, F. Abd-Allah, A. M. Abdulle, S. F. Abera, G. Y. Abyu, M. B. Ahmed, A. N. Aichour, I. Aichour, Lancet Neurol. 2017, 16, 877-897.
    1. M. Goedert, M. G. Spillantini, K. Del Tredici, H. Braak, Nat. Rev. Neurol. 2013, 9, 13.
    1. S. Moussaud, D. R. Jones, E. L. Moussaud-Lamodiere, M. Delenclos, O. A. Ross, P. J. McLean, Mol. Neurodegener. 2014, 9, 43.
    1. E. R. Dorsey, B. R. Bloem, JAMA Neurol. 2018, 75, 9-10.
    1. G. Fusco, A. De Simone, T. Gopinath, V. Vostrikov, M. Vendruscolo, C. M. Dobson, G. Veglia, Nat. Commun. 2014, 5, 3827.

Publication types

LinkOut - more resources